Related Experiment Video
Updated: May 13, 2026
07:31
A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
Published on: February 13, 2020
Communications training in pharmacy education, 1995-2010
Andy Wallman1, Cristina Vaudan, Sofia Kälvemark Sporrong
1Department of Chemistry, Umeå University, Umeå, Sweden. wallman@chem.umu.se
American Journal of Pharmaceutical Education
|March 23, 2013
Summary
Pharmacists are vital communicators, but pharmacy education struggles to effectively train these skills. Integrated learning activities and curriculum progression are crucial for developing essential communication competency in pharmacy students.
Area of Science:
- Pharmacy Education
- Communication Skills Training
Background:
- The pharmacist's role as a communicator is essential for patient care and interprofessional collaboration.
- Current pharmacy curricula face challenges in effectively equipping students with necessary communication skills.
Purpose of the Study:
- To review peer-reviewed literature on communication training in pharmacy education.
- To identify targeted communication skills and assess the effectiveness of learning activities.
Main Methods:
- Systematic literature search of published, peer-reviewed articles.
- Categorization of articles based on communication skills and learning activity types.
- Analysis of assessment methods for educational interventions.
Main Results:
- Oral interpersonal communication skills for patients were most frequently addressed, followed by clinical writing.
- Simulated patient interactions and practice experiences were common teaching methods.
- Most interventions relied on subjective assessment measures, with many described in isolation.
Conclusions:
- Effective communication training in pharmacy requires integrated learning activities and a progressive curriculum.
- Further research is needed to analyze the impact of fragmented interventions and improve assessment strategies.
Related Concept Videos
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
01:28Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
01:26Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).